Respiratory Syncytial Virus Rsv Infections Drug Market

Respiratory Syncytial Virus (RSV) Infections Drug Market Size, By Product Type (Antibiotics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cough Suppressants, Nasal Decongestants, Others), By Application (Drug Stores and Retail Pharmacies, Hospital Pharmacies, Others), By Key Players (GlaxoSmithKline plc, Merck & Co., Inc., AstraZeneca, Boehringer Ingelheim International, Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Sanofi, Cipla, Inc., CHIESI Farmaceutici S.p.A., Orion Corporation), By Regional Outlook And Competitive Landscape Forecast To 2032

Report ID: RV293367 | Published: Jan 2024 | Historical Period: 2018-2022 | Pages: 176 | Price: $3260| Industry: Pharma and Healthcare
50-Percent-Sale

To Learn More About This Report

Our Clients